Min Yan

19.9k total citations · 4 hit papers
392 papers, 11.7k citations indexed

About

Min Yan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Min Yan has authored 392 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Molecular Biology, 123 papers in Pulmonary and Respiratory Medicine and 118 papers in Oncology. Recurrent topics in Min Yan's work include Gastric Cancer Management and Outcomes (62 papers), HER2/EGFR in Cancer Research (37 papers) and Gastrointestinal Tumor Research and Treatment (35 papers). Min Yan is often cited by papers focused on Gastric Cancer Management and Outcomes (62 papers), HER2/EGFR in Cancer Research (37 papers) and Gastrointestinal Tumor Research and Treatment (35 papers). Min Yan collaborates with scholars based in China, United States and United Kingdom. Min Yan's co-authors include Bingya Liu, Liping Su, Zhenggang Zhu, Jianfang Li, Beiqin Yu, Gaoming Liao, Xia Li, Yun Xiao, Liwen Xu and Quentin Liu and has published in prestigious journals such as Nucleic Acids Research, Nature Medicine and Nature Communications.

In The Last Decade

Min Yan

365 papers receiving 11.6k citations

Hit Papers

CellMarker: a manually curated resource of cell markers i... 2015 2026 2018 2022 2018 2018 2018 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CellMarker: a manually curated resource of cell markers in human and mouse
    2018 893 citations Chunyu Deng, Liwen Xu et al. profile →
  2. CancerSEA: a cancer single-cell state atlas
    2018 597 citations Huating Yuan, Min Yan et al. profile →
  3. TIP: A Web Server for Resolving Tumor Immunophenotype Profiling
    2018 476 citations Liwen Xu, Chunyu Deng et al. Cancer Research profile →
  4. HER2 expression status in diverse cancers: review of results from 37,992 patients
    2015 358 citations Min Yan, Razelle Kurzrock et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Yan China 55 6.5k 4.0k 3.2k 2.7k 1.3k 392 11.7k
Ylermi Soini Finland 59 5.8k 0.9× 2.7k 0.7× 3.5k 1.1× 2.7k 1.0× 1.5k 1.2× 283 12.2k
Yulin Liao China 56 5.8k 0.9× 2.8k 0.7× 2.0k 0.6× 1.9k 0.7× 1.5k 1.1× 244 11.5k
Kazuaki Takabe United States 60 7.0k 1.1× 2.8k 0.7× 4.3k 1.4× 2.3k 0.8× 1.3k 1.0× 398 12.6k
Adriana Heguy United States 60 6.9k 1.1× 2.9k 0.7× 3.2k 1.0× 2.3k 0.9× 730 0.6× 178 14.0k
Bingya Liu China 58 6.9k 1.1× 4.6k 1.2× 2.5k 0.8× 1.4k 0.5× 943 0.7× 295 10.5k
Dan Xie China 69 11.2k 1.7× 6.5k 1.6× 3.5k 1.1× 1.9k 0.7× 1.3k 1.0× 361 16.0k
Samy Lamouille United States 17 7.4k 1.1× 3.2k 0.8× 4.2k 1.3× 1.5k 0.5× 827 0.6× 24 11.4k
Jiří Zavadil United States 56 8.1k 1.2× 2.7k 0.7× 2.9k 0.9× 1.1k 0.4× 771 0.6× 147 12.6k
Yoji Nagashima Japan 54 5.7k 0.9× 2.2k 0.6× 2.2k 0.7× 3.4k 1.3× 1.6k 1.2× 415 11.3k
Derek C. Radisky United States 61 7.1k 1.1× 3.8k 1.0× 5.9k 1.9× 1.7k 0.6× 888 0.7× 196 14.3k

Countries citing papers authored by Min Yan

Since Specialization
Citations

This map shows the geographic impact of Min Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Yan more than expected).

Fields of papers citing papers by Min Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Yan. The network helps show where Min Yan may publish in the future.

Co-authorship network of co-authors of Min Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Min Yan. A scholar is included among the top collaborators of Min Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Yan. Min Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Hao, et al.. (2025). Docetaxel rechallenge in HER2-negative metastatic breast cancer: a real-world study of previously discontinued patients for non-progression reasons. Journal of Cancer Research and Clinical Oncology. 151(2). 89–89. 1 indexed citations
2.
Zhang, Ting, Xiaohui Hou, Min Yan, et al.. (2024). Apple polyphenols prevent patulin-induced intestinal damage by modulating the gut microbiota and metabolism of the gut-liver axis. Food Chemistry. 463(Pt 1). 141049–141049. 8 indexed citations
3.
Xu, Binghe, Shusen Wang, Min Yan, et al.. (2024). Sacituzumab govitecan in HR+HER2− metastatic breast cancer: the randomized phase 3 EVER-132-002 trial. Nature Medicine. 30(12). 3709–3716. 14 indexed citations
4.
5.
6.
Yan, Min, Limin Niu, Mengwei Zhang, et al.. (2023). Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trial. Nature Communications. 14(1). 6272–6272. 7 indexed citations
7.
8.
9.
Gao, Hongfei, Min Yan, Qianjun Chen, et al.. (2023). Effectiveness and Safety of Palbociclib Plus Endocrine Therapy in Patients with Advanced Breast Cancer: A Multi-Center Study in China. Cancers. 15(17). 4360–4360. 2 indexed citations
10.
Feng, Xijia, et al.. (2022). Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study. Frontiers in Pharmacology. 13. 845261–845261. 4 indexed citations
11.
Zhu, Zhenglun, Hongpeng Shi, Tienan Feng, et al.. (2019). Expanding the indication of endoscopic submucosal dissection for undifferentiated early gastric cancer is safe or not?. Asian Journal of Surgery. 43(4). 526–531. 9 indexed citations
12.
Xu, Liwen, Chunyu Deng, Bo Pang, et al.. (2018). TIP: A Web Server for Resolving Tumor Immunophenotype Profiling. Cancer Research. 78(23). 6575–6580. 476 indexed citations breakdown →
13.
Li, Jianbin, Shusen Wang, Yongsheng Wang, et al.. (2017). Disparities of Trastuzumab Use in Resource-Limited or Resource-Abundant Regions and Its Survival Benefit on HER2 Positive Breast Cancer: A Real-World Study from China. The Oncologist. 22(11). 1333–1338. 35 indexed citations
14.
Zheng, Fei-Meng, Caifeng Yue, Guohui Li, et al.. (2016). Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nature Communications. 7(1). 10180–10180. 146 indexed citations
15.
Wang, Zifeng, Jiajun Xie, Min Yan, et al.. (2016). Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma. Oncotarget. 7(18). 26765–26779. 21 indexed citations
16.
Yan, Min, Barbara A. Parker, Richard B. Schwab, & Razelle Kurzrock. (2014). HER2 aberrations in cancer: Implications for therapy. Cancer Treatment Reviews. 40(6). 770–780. 175 indexed citations
17.
Long, Zi-Jie, et al.. (2013). Inhibition of mTOR Pathway Sensitizes Acute Myeloid Leukemia Cells to Aurora Inhibitors by Suppression of Glycolytic Metabolism. Molecular Cancer Research. 11(11). 1326–1336. 59 indexed citations
18.
Yan, Min, Huimin Lü, Zhenzhen Liu, et al.. (2013). High risk factors of brain metastases in 295 patients with advanced breast cancer. Chinese Medical Journal. 126(7). 1269–1275. 14 indexed citations
19.
Wei, Min, Bingya Liu, Liping Su, et al.. (2010). A Novel Plant Homeodomain Finger 10–Mediated Antiapoptotic Mechanism Involving Repression of Caspase-3 in Gastric Cancer Cells. Molecular Cancer Therapeutics. 9(6). 1764–1774. 21 indexed citations
20.
Wang, Lihui, Jin Xiang, Min Yan, et al.. (2010). The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway. Cancer Research. 70(22). 9118–9128. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ylermi Soini Breakdown of academic impact, for papers by Yulin Liao Breakdown of academic impact, for papers by Kazuaki Takabe Breakdown of academic impact, for papers by Adriana Heguy Breakdown of academic impact, for papers by Bingya Liu Breakdown of academic impact, for papers by Dan Xie Breakdown of academic impact, for papers by Samy Lamouille Breakdown of academic impact, for papers by Jiří Zavadil Breakdown of academic impact, for papers by Yoji Nagashima Breakdown of academic impact, for papers by Derek C. Radisky
Rankless by CCL
2026